Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

EXPERTS have warned over hundreds rushed to hospital after using weight loss jabs – as half a million Brits now use the ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Maintaining a healthy weight is good for your body and can also help with self-esteem. If you’ve been trying to lose weight, ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

For many struggling with weight management, new medications like Wegovy, Mounjaro, and Saxenda have been seen as ...

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

If that person loses 20 kilograms (44 pounds) in one year while taking a GLP-1R agonist — which is not unreasonable while ...

There are currently three medications (GLP-1s) on the market that the FDA has specifically approved to treat obesity — Wegovy, Zepbound, or Saxenda. Other common weight-loss medications like ...